Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : IMDS nasdaq bulletin board -- Ignore unavailable to you. Want to Upgrade?

To: kenita who wrote (3414)	5/24/1999 12:01:00 PM
From: gao seng	Read Replies (1) \| Respond to of 4122

More tortuous misrepresentations by the emotionally challenged former employee and friend of the people at IMDS: Kenita, please seek help. On May 5, 1999, Nassau County orally provided the Company with the following conditions in order to begin the clinical studies: 34 <PAGE> 1. No patient information, i.e., mammography, ultrasound, and/or ultrasound films or reports would be released to the Company until all 275 patients have been scanned, 2. NCMC medical staff would select, without the Company's involvement and knowledge of the patient's condition, all patients that are examined, and 3. IDSI was asked to pay 6-months of testing expenses in advance. The conditions, as of May 10, 1999, imposed by Nassau County essentially prevent IDSI from performing any comparisons until all 275 volunteers have been scanned with the CTLM. These conditions are in direct contradiction to the previously accepted IDE protocol, and have been caused, the Company believes, as a direct result of the Miami Herald article and tortuous acts by certain individuals. The Company believes that the "blind study" proposed by Nassau County would defeat the purpose of the clinical investigational trials. If the Company accepts the new protocol, in order to proceed with the study it would have to amend and resubmit the IDE protocol.